Popular Articles

Sotomayor Signals Support For Roe V. Wade In Meetings With Senators
Supreme Court nominee Sonia Sotomayor in conversations with senators has indicated her support for Roe v. Wade, even if she has not explicitly stated that she supports abortion rights, the AP/Yahoo! News reports. According to the AP/Yahoo! News, Sotomayor is "following a time-honored tradition" among nominees of assuring senators that she will not aim to impose a certain agenda, while also avoiding firm commitments on how she might rule on certain issues -- such as abortion rights -- if they come before the court. In questioning Sotomayor, senators hope to obtain assurances that she will honor certain precedents, such as Roe, which allows them to justify their votes for her to their constituents, the AP/Yahoo! News reports. Doug Kendall of the Constitutional Accountability Center said, "There"s always a bit of a parlor game that develops in terms of what precisely words said by nominees mean."Because Sotomayor has never directly ruled on the key issues in Roe, advocates on both sides of the abortion-rights debate have speculated over her views on constitutional privacy rights. White House spokesperson Robert Gibbs has said that President Obama and Sotomayor discussed her "views on unenumerated rights in the Constitution and the theory of settled law." The AP/Yahoo! News reports that Gibbs" comments indicate that Sotomayor would be unlikely to overturn Roe, which supporters consider "settled law." Sens. Dianne Feinstein (D-Calif.) and Benjamin Cardin (D-Md.), both of whom support abortion rights, said they spoke with Sotomayor about her position during private meetings and were pleased with her answers. Feinstein said that Sotomayor is "a woman who is well-steeped in the law and well-steeped in precedent, and I believe that she has a real respect for precedent." Sen. Jim DeMint (R-S.C.), an opponent of abortion rights, said that when he privately asked Sotomayor whether she believed a fetus should have any constitutional rights, she responded that she had never considered the issue (Hirschfeld Davis, AP/Yahoo! News, 6/18).
generic viagra online
$1 Million For Memory Research Awarded To UTSA Psychologist
University of Texas at San Antonio Assistant Professor of Psychology Rebekah Smith has been awarded a five-year, $1 million grant from the National Institutes of Health to study adult memory. To conduct the research, beginning in July, Smith will be recruiting younger adult volunteers aged 18-30 and older adults, aged 60 and above.
News of the day
Abraxis Bioscience Completes Enrollment Of Pivotal Phase III Advanced Lung Cancer Study Evaluating Abraxane(R) Vs. Taxol(R)
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated biotechnology company, announced that the company has completed patient enrollment of a pivotal, phase III clinical study comparing the company"s chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin bound) with Taxol® (paclitaxel) injection, both in combination with carboplatin, in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC). The study, which is being conducted at 111 sites globally, includes 1,050 patients and is being led by principal investigator Dr. Mark Socinski at the University of North Carolina Lineberger Comprehensive Cancer Center. It is one of the largest NSCLC clinical studies to complete enrollment.
Medical Devices

Applied Infectious Disease Epidemiology Conference, Stockholm, Stockholm, October 26-28, 2009

"Epidemiology is always important and topical, though sometimes unsung," says Professor Johan Giesecke, Chief Scientist at ECDC, the European Centre for Disease Prevention and Control, "but the third applied Infectious Disease Epidemiology Conference in Stockholm in October this year will be an opportunity to put Epidemiology and infectious disease prevention and control into the spotlight; delegates will have the opportunity to discuss and share information on current and emerging infectious diseases, including influenza A (H1N1)v. The call for abstracts closes on July 3rd so there is no time to lose." "Let me stress," he adds, "that influenza is not the only topic. We welcome abstracts relating to all infectious diseases in areas of applied public health research, outbreak investigations and public health surveillance. We also welcome abstracts in other areas of applied epidemiology or public health practice in which results are linked to public health action. We have an easy-to-use online system for abstract submission and conference registration to be found at http://www.escaide.eu. And it is not to soon to register. Remember, Sweden has the Presidency of the EU in the second half of this year, so we advise you to book your flights and hotel early." The European Centre for Disease Prevention and Control - ECDC - will host the third annual European Scientific Conference on Applied Infectious Disease Epidemiology - ESCAIDE - in Stockholm, home to the ECDC, from October 26-28. The event is being organized in partnership with the European Programme for Intervention Epidemiology Training (EPIET) and the EPIET Alumni network (EAN). It is a unique opportunity for frontline professionals from national disease control institutes to engage with each other and the wider scientific community. The Conference aims at: - strengthening and expanding the network of all those involved in applied infectious disease epidemiology; - sharing scientific knowledge and experience in this field in Europe and internationally; and - providing a dedicated platform for fellows of the EPIET/FETP (field epidemiology training program) to present their work. ESCAIDE 2009 is expecting participation of up to 500 health experts from more than 60 countries. The application for ESCAIDE to be accredited by the European Accreditation Council for Continuing Medical Education (EACCME) as in 2008 is under way. This should enable participants to be granted up to a maximum of 18 CME credits for participating in the conference while the registration costs will remain low. More information can be found at http://www.escaide.eu ECDC Set up in 2005 and headquartered in Stockholm, the European Centre for Disease Prevention and Control (ECDC) is a EU agency which aims to strengthen Europe"s defences against infectious diseases. ECDC"s mission is to identify, assess and communicate current and emerging threats to human health posed by infectious diseases. In order to achieve its mission, ECDC works in partnership with national health protection bodies across Europe to strengthen and develop continent-wide disease surveillance and early warning systems. By working with experts throughout Europe, ECDC pools Europe"s health knowledge, so as to develop authoritative scientific opinions about the risks posed by current and emerging infectious diseases. EPIET EPIET is the European Programme for Intervention Epidemiology Training, which provides training and practical experience in intervention epidemiology at the national centres for surveillance and control of communicable diseases in the European Union (EU). Presentation of EPIET diplomas will be the closing event of the Conference. ECDC


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):